Evolution of antibiotic treatments for healthcare-associated infections caused by extended-spectrum beta-lactamase-producing Enterobacteriaceae in France

Infectious Diseases Now(2022)

引用 0|浏览6
暂无评分
摘要
•Nationwide study, using data from Point Prevalance studies in acute care hospitals.•Decrease in carbapenem and aminoglycoside use between 2012 and 2017, in patients with an ESBL-producing Enterobacteriaceae HAI:•Treatment durations remain longer than recommended.•Results can serve to direct future efforts in antimicrobial stewardship.
更多
查看译文
关键词
Enterobacteriaceae,Extended-spectrum beta-lactamase,Antibiotics,Point prevalence survey,Healthcare-associated infections
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要